Clinical Trial Update: Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion and posting of results from a Phase 2 study evaluating LCQ908 for non-alcoholic fatty liver disease, focusing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• LCQ908

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Non-alcoholic Fatty Liver Disease (NAFLD) | Phase 2 | Status: COMPLETED | Results posted: 2016-02-04